DKIS LLC executes two-level model of global development of ISVAC™
- The two-level model implies that the product is developed and manufactired in full compliance to international standards of pharmaceutical practices, however, sent for early stage clinical trials to an emerging country where time and cost may be saved due to easier patient and professional recruitment
- We chose to run ISVAC™ clinical trials in Russia
- At the first stage of ISVAC™ development it will be produced at European CMO and investigated at Chinese CRO. Then ISVAC™ will go to clinical studies in Russia overlooked by CRO with international reputation. After completing clinical trials ISVAC™ will be forwarded parallel routes of registration and marketig in Russia, and further clinical studies in developed countries
